These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 761192)

  • 1. Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.
    Morris DL; Hersh EM; Hsi BP; Gutterman JU; Marshall MM; Mavligit GM
    Cancer Res; 1979 Jan; 39(1):219-26. PubMed ID: 761192
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity skin reactions in the induction phase of remission in acute non lymphoid leukemias.
    Vu Van H; Fiere D; Doillon M; Martin C; Coiffier B; Revol L
    Biomedicine; 1978; 28(3):166-9. PubMed ID: 279357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemia.
    Frydecka I; Becker M
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):645-7. PubMed ID: 6935989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous, cellular immunity in malignant melanoma].
    Kehrer HC
    Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Technic and significance of the intracutaneous test with recall antigens in general surgery].
    Dürig M; Heberer M; Harder F
    Chirurg; 1982 Jul; 53(7):427-30. PubMed ID: 7117004
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
    Nakai N; Katoh N; Germeraad WT; Kishida T; Ueda E; Takenaka H; Mazda O; Kishimoto S
    J Dermatol Sci; 2009 Jan; 53(1):40-7. PubMed ID: 18804963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed skin hypersensitivity in man. The effect of repeated tests with low-dose antigen.
    Merk K; Björkholm M; Holm G; Mellstedt H
    Acta Derm Venereol; 1988; 68(5):450-3. PubMed ID: 2461034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recall skin-test antigens and the prognosis of stage I melanoma.
    Aranha GV; McKhann CF; Simmons RL; Grage TB
    J Surg Oncol; 1979; 11(1):13-6. PubMed ID: 431077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity skin testing. A review.
    Ahmed AR; Blose DA
    Arch Dermatol; 1983 Nov; 119(11):934-45. PubMed ID: 6639116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
    Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
    Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental induction of the delayed reaction as immunologica indicator (in dermatoses, tumors, immunosuppression)].
    Remy W; Stüttgen G
    Allerg Immunol (Leipz); 1972; 18(2):97-104. PubMed ID: 4266967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
    Stenger D; Delbrück H; Krumrey K; Zaun H
    Z Hautkr; 1983 Mar; 58(5):293-304. PubMed ID: 6845797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of soluble human melanoma-associated antigens.
    Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
    Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
    Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
    Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens.
    Lesourd BM; Winters WD; Kniker WT
    J Clin Lab Immunol; 1986 Apr; 19(4):187-92. PubMed ID: 3723589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.